Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
As leaders in blood and blood cancer research, physicians and scientists from Dana-Farber Cancer Institute shared advances and insights at the 62nd Annual Meeting of the American Society of Hematology (ASH).
This page offers presentation schedules for our faculty; explainer videos; program and clinical trial information; and more.
Stay current on Twitter: #ASH20
Saturday, December 5Sunday, December 6Monday, December 7
Dr. Corey Cutler presented evidence demonstrating that a donor stem cell transplant can improve survival rates for older patients with higher-risk myelodysplastic syndrome (MDS).
Dr. Caron Jacobson presented the primary analysis of Zuma-5, a phase 2 study of axicabtagene ciloleucel (axi-cel) in patients with relapsed/refractory (R/R) indolent non-Hodgkin lymphoma.
Edward J. Benz, Jr., MD ASH Award for Leadership in Promoting Diversity
Annamaria Gullà, MD2020 Joanne Levy, MD, Memorial Award for Outstanding AchievementProject title: "Bortezomib Induces Anti-Multiple Myeloma Immune Response Mediated by Cgas/Sting Pathway Activation, Type I Interferon Secretion, and Immunogenic Cell Death: Clinical Application"
Elisa ten HackenASH Abstract Achievement AwardASH Scholar Award
Kirsty Hillier, MDASH Research Training Award for Fellows
Peter Miller, MD, PhDASH Research Training Award for Fellows
Samuel Ng, MD, PhDASH Scholar Fellow to Faculty Award in Basic/Translational ResearchProject title: Mechanistic Insight to Target BATF3-IRF4 Transcription Factor Complexes in Peripheral T-cell Lymphoma"
Oreofe Odejide, MD, MPHASH Junior Faculty Scholar Award for Clinical ResearchProject title: "An Intervention for Fear of Cancer Recurrence Among Lymphoma Survivors"
For ASH 2020 media inquiries, contact Claire Monaghan, Senior Media Relations Specialist, at claire_monaghan@dfci.harvard.edu.
More from Our Center for Hematologic Oncology Subscribe to our Advances in Hematologic Malignancies e-newsletter. Past issues Learn more about our specialized programs and teams. Access our resources for physicians. Explore our clinical trials for blood cancers, stem cell transplant, and cellular therapies.
More from Our Center for Hematologic Oncology
Subscribe to our Pediatric Hematology/Oncology E-Newsletter Stay informed about our pediatric clinical trials research efforts. Subscribe to our Advances in Pediatric Hematology/Oncology email newsletter. Subscribe now
Subscribe to our Pediatric Hematology/Oncology E-Newsletter
Stay informed about our pediatric clinical trials research efforts. Subscribe to our Advances in Pediatric Hematology/Oncology email newsletter.
Subscribe now
View Dana-Farber highlights from previous ASH meetings